Printer Friendly

Bluegrass Vascular Secures CE Mark Approval for Surfacer Inside-Out Access Catheter System.

M2 PHARMA-August 31, 2016-Bluegrass Vascular Secures CE Mark Approval for Surfacer Inside-Out Access Catheter System

(C)2016 M2 COMMUNICATIONS

- US-based medical technology company Bluegrass Vascular Technologies has received CE Mark approval and is launching limited commercial sale of its Surfacer Inside-Out Access Catheter System, the company said.

The Surfacer System is indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel Inside-Out approach.

This system is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the femoral vein and navigating it up through the patient's venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter.

According to Bluegrass, the proprietary Inside-Out approach allows for the placement and maturation of permanent arteriovenous access options that are associated with improved patient outcomes and reduced cost of care for both hospitals and hemodialysis providers.

The company has launched the Surfacer System in limited markets, including the UK, Germany,Austria, Italy, and the Benelux.

Bluegrass will also commence enrollment of the Surfacer System to Facilitate Access in Venous Occlusions Study, an observational, post-market registry for patients with limited or diminishing upper body venous access or pathology impeding standard access methods.

The United States Patent and Trademark Office (USPTO) recently issued two patents related to Bluegrass Vascular's technology for the Surfacer Inside-Out Access Catheter System. US patent number 9,289,577 B2, "Occlusion Access System," covers a method for providing access to a central venous system of a patient.

US patent number 9,314,595 B2, "Central Venous Access System" covers a catheter system for use in accessing a patient's central venous system at a location near the neck.

Bluegrass Vascular Technologies is a medical technology company focused on developing and commercializing lifesaving devices and methods that address shortcomings in vascular access procedures.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Aug 31, 2016
Words:325
Previous Article:Atossa Genetics to issue common stock in public offering.
Next Article:Qualcomm, Boehringer Ingelheim Pharmaceuticals Work to Add New Digital Technology to Respimat inhaler.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters